Heptane
![Medchemexpress LLC 2-cyano-N-{[(3,4-dichlorophenyl)carbamothioyl]amino}acetamide | 656222-54-7 | MFCD00119122 | 99.8% | 303.17 g/mol | C10H8Cl2N4OS | 100MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000235492.png-250.jpg)
Medchemexpress LLC 2-cyano-N-{[(3,4-dichlorophenyl)carbamothioyl]amino}acetamide | 656222-54-7 | MFCD00119122 | 99.8% | 303.17 g/mol | C10H8Cl2N4OS | 100MG
iKIX1 is an antifungal research compound that resensitizes drug-resistant Candida glabrata to azole antifungals by inhibiting the interaction between the KIX domain of mediator subunit CgGal11A and the activation domain of CgPdr1. It is used for in vitro studies of multidrug resistance and fungal infection models.
- Molecular formula: C10H8Cl2N4OS.
- Molecular weight: 303.17 g/mol.
- Purity: 99.8% (HPLC).
- Appearance: off-white to light yellow solid.
- Solubility: DMSO 83.33 mg/mL (≈274.9 mM); may require ultrasonic.
- Storage: powder -20°C (up to 3 years); in solution -80°C (6 months), -20°C (1 month).
- Available sizes: solid quantities from milligram to gram scale and 10 mM solutions in DMSO.
Medchemexpress LLC Zanzalintinib | 2367004-54-2 | 99.91% | 528.53 | 50 MG
Zanzalintinib (XL092) is an orally active, ATP-competitive inhibitor of multiple receptor tyrosine kinases (RTKs) including MET, VEGFR2, AXL, and MER. It exhibits anti-tumor activity and has potential for research in kinase-dependent diseases and conditions.
- Orally active, ATP-competitive inhibitor
- Targets MET, VEGFR2, AXL, and MER
- Exhibits anti-tumor activity
- Potential for kinase-dependent diseases and conditions research
![Medchemexpress LLC 2-cyano-N-{[(3,4-dichlorophenyl)carbamothioyl]amino}acetamide | 656222-54-7 | MFCD00119122 | 99.8% | 303.17 | C10H8Cl2N4OS | 25MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000237141.png-250.jpg)
Medchemexpress LLC 2-cyano-N-{[(3,4-dichlorophenyl)carbamothioyl]amino}acetamide | 656222-54-7 | MFCD00119122 | 99.8% | 303.17 | C10H8Cl2N4OS | 25MG
iKIX1 is a small-molecule antifungal research compound that disrupts the interaction between the KIX domain of the mediator subunit CgGal11A and the activation domain of CgPdr1, and it resensitizes azole-resistant Candida glabrata in vitro. The compound has formula C10H8Cl2N4OS and a molecular weight of 303.17 g·mol⁻¹; it is supplied for research use only.
- Inhibits KIX-activation domain interaction (IC50 190.2 μM; Ki 18 μM).
- Resensitizes azole-resistant Candida glabrata in vitro.
- Supplied for research use only; not for clinical use.
- High purity (99.8% as reported by manufacturer).
- Stable as powder at -20°C for up to 3 years; in solvent stored at -80°C (6 months) or -20°C (1 month).
- Available as solid and as DMSO solution formulations for convenient handling.
Sigma Aldrich Fine Chemicals Biosciences Heptane biotech. grade, >=99% | 142-82-5 | MFCD00009544 | 1L
Heptane biotech. grade, >=99% | Purity: >=99% | Mol Wt: 100.2 | 142-82-5 | MFCD00009544 | 1L
eMolecules 2447575-76-8 | Ambeed | (4R4R)-22-(Heptane-44-diyl)bis(4-phenyl-45-dihydrooxazole) | 100mg | 665578667 | A1505736 | 390.527 | C25H30N2O2
Ambeed | 2-(Phenylethynyl)benzaldehyde | 1g | 524998871 | A108980 | 59046-72-9 | MFCD09030317 | 206.244 | C15H10O
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Sigma Aldrich Fine Chemicals Biosciences Heptane suitable for HPLC, >=96% | 142-82-5 | MFCD00009544 | 1L
Heptane suitable for HPLC, >=96% | Purity: >=96% | Mol Wt: 100.2 | 142-82-5 | MFCD00009544 | 1L
Sigma Aldrich Fine Chemicals Biosciences Heptane suitable for HPLC, >=99% | 142-82-5 | MFCD00009544 | 6X1L
Heptane suitable for HPLC, >=99% | Purity: >=99% | Mol Wt: 100.2 | 142-82-5 | MFCD00009544 | 6X1L
eMolecules AstaTech / 4-BENZENESULFONYLBENZOIC ACID / 0.25g / 434268179 / 26942 / 95.000 / 5361-54-6 / MFCD00568775 / 262.280 / C13H10O4S
AstaTech / 4-BENZENESULFONYLBENZOIC ACID / 0.25g / 434268179 / 26942 / 95.000 / 5361-54-6 / MFCD00568775 / 262.280 / C13H10O4S
![Medchemexpress LLC 2-[[4-[(2-methoxybenzoyl)amino]benzoyl]amino]benzoic acid | 693241-54-2 | MFCD03624354 | 98.3% | 390.4 g·mol⁻1 | C22H18N2O5 | 50MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000237072.png-250.jpg)
Medchemexpress LLC 2-[[4-[(2-methoxybenzoyl)amino]benzoyl]amino]benzoic acid | 693241-54-2 | MFCD03624354 | 98.3% | 390.4 g·mol⁻1 | C22H18N2O5 | 50MG
EG1 is a small-molecule inhibitor of the Pax2 transcription factor that binds the Pax2 paired domain (Kd ≈ 1.35-1.5 μM) and inhibits Pax2-DNA interactions. It has been used to inhibit embryonic kidney development and to reduce viability of Pax2-positive renal cancer cell lines. Supplied as a purified research reagent with recommended storage conditions for powder and solutions.
- Inhibits Pax2 DNA binding and transcriptional activity.
- Demonstrated activity in developmental and renal cancer cell models.
- High purity (98.3%) suitable for research applications.
- Available in multiple pack sizes and a DMSO solution format.
- Stable under recommended storage conditions for powder and in solvent.